Egrifta (Tesamorelin) Nutrition for Best Outcomes

What Tesamorelin Does and Why Nutrition Matters

Tesamorelin is a synthetic analogue of growth hormone-releasing factor (GRF). It binds pituitary GRF receptors and stimulates pulsatile GH secretion, which in turn raises IGF-1 and drives lipolysis in visceral adipose depots. In the key LIPO-010 trial (N=412), 26 weeks of tesamorelin 2 mg/day reduced VAT by 15.2% versus 1.8% in the placebo group (P<0.001). [1]

Diet shapes two of the three key variables that determine how well tesamorelin works: insulin sensitivity and the metabolic substrate environment. GH is inherently counter-regulatory to insulin, meaning any dietary pattern that already stresses glucose metabolism will compound the drug's mild diabetogenic tendency. A thoughtfully designed eating plan does not just protect metabolic safety, it creates the biochemical conditions under which GH-driven lipolysis proceeds most efficiently.

How GH Lipolysis Interacts With What You Eat

GH-stimulated lipolysis releases free fatty acids from visceral adipocytes into portal circulation. If dietary fat and refined carbohydrate load is simultaneously high, hepatic lipid re-esterification competes with oxidation. The net result: triglycerides may remain elevated even as VAT shrinks. Keeping dietary saturated fat below 10% of total calories and refined carbohydrate below 25% of total calories gives the liver a cleaner substrate stream.

The Insulin Sensitivity Window

GH pulses occur predominantly overnight and in the early morning. Insulin sensitivity is highest in this same window. A light, low-glycemic breakfast eaten 30 to 60 minutes after the morning injection exploits this physiology. A breakfast centered on oats (glycemic index ~55), eggs, and non-starchy vegetables produces a modest, flat insulin curve that does not blunt the GH pulse already underway.

Macronutrient Targets on Tesamorelin

A structured macronutrient framework gives patients and their care teams a measurable target rather than vague guidance to "eat healthily." The three priorities are glucose stability, lean mass retention, and triglyceride control.

Carbohydrates: Prioritize Quality Over Quantity

Total carbohydrate restriction is not required on tesamorelin. What matters more is glycemic index (GI) and fiber content. A 2022 systematic review in Diabetes Care confirmed that low-GI diets reduce HbA1c by approximately 0.5 percentage points and fasting glucose by 0.86 mmol/L compared with higher-GI comparators across diverse populations, including people living with HIV (PLWH). [2]

Practical targets for tesamorelin patients:

• Aim for 40 to 50% of calories from carbohydrate, weighted toward GI <55 sources
• Minimum 25 g dietary fiber per day from vegetables, legumes, and whole grains
• Limit added sugars to <25 g/day (aligned with WHO guidance [3])
• Avoid liquid carbohydrates (juice, sugar-sweetened beverages, alcohol mixers) at the tesamorelin injection window

Legumes deserve special mention. Lentils, chickpeas, and black beans simultaneously provide low-GI carbohydrate, plant protein, and soluble fiber. Each of these properties supports the metabolic goals above.

Protein: Building the Case for 1.2 to 1.6 g/kg/day

HIV-associated lipodystrophy involves not just excess VAT but often reduced lean mass in the limbs. Tesamorelin selectively targets VAT and does not directly rebuild muscle, so adequate dietary protein is the primary lever for preserving or increasing skeletal muscle during treatment.

The 2019 AACE Clinical Practice Guidelines recommend 1.2 to 1.5 g/kg/day of high-quality protein for adults with metabolic disease who are in a caloric deficit or on body-composition-altering therapies. [4] For a 70 kg patient, that translates to 84 to 105 g of protein daily, distributed across at least three meals to maximize muscle protein synthesis.

Sources to prioritize:

• Lean poultry, fish (especially fatty fish for omega-3 co-benefits), egg whites
• Low-fat dairy or fortified plant equivalents (for leucine content)
• Legumes combined with whole grains to form complete amino acid profiles

Protein also carries a meaningful satiety advantage. Higher-protein meals reduce ghrelin and increase PYY, which may help patients adhere to caloric targets without hunger.

Dietary Fat: Type Matters More Than Total Amount

Tesamorelin modestly raises triglycerides in some patients. The LIPO-010 extension data showed mean triglyceride increases of approximately 8 to 12 mg/dL in the tesamorelin arm versus placebo after 52 weeks. [1] Adjusting dietary fat composition can offset this tendency.

Reduce: Saturated fat (red meat, full-fat dairy, tropical oils) to <10% of total calories. Emphasize: Monounsaturated fats (olive oil, avocado, almonds) and long-chain omega-3 polyunsaturated fats (EPA/DHA from fatty fish or algal oil supplements, 1 to 2 g/day).

A 2019 meta-analysis in JAMA Cardiology found that omega-3 supplementation at 4 g/day reduced triglycerides by 14 to 30% in populations with elevated baseline levels. [5] Lower doses (1 to 2 g/day) produce more modest but still clinically relevant reductions for patients on tesamorelin whose triglycerides are mildly elevated.

Meal Timing and the Tesamorelin Injection Window

The FDA-approved prescribing information for Egrifta specifies that the injection should be given on an empty stomach. [6] This is not arbitrary. GH secretagogues interact with ghrelin pathways that are suppressed by acute nutrient intake, and animal pharmacokinetic data suggest that postprandial GI peptide activity may attenuate GRF receptor binding.

Practical Morning Protocol

A workable daily sequence for most patients:

1. Wake. Inject tesamorelin into the abdomen, thigh, or deltoid.
2. Wait 30 minutes minimum before eating.
3. Eat a low-GI, moderate-protein breakfast.
4. Take antiretroviral medications per individual schedule (most regimens are food-neutral or food-positive and do not conflict with this window).

Some patients find a 45-minute fasted window easier to sustain if they take the injection immediately before a morning walk or resistance training session. This pattern aligns tesamorelin's GH peak with the post-exercise anabolic window, a potential additive benefit that warrants prospective study.

Evening Injections: An Alternative for Shift Workers

The prescribing information does not mandate morning dosing. Patients who work nights or who have difficulty fasting in the morning may inject in the evening, again on an empty stomach at least 30 minutes before a meal. The metabolic rationale for evening dosing is somewhat stronger from a physiological standpoint because endogenous GH secretion peaks during slow-wave sleep; replicating that pulse pharmacologically during the early sleep cycle is reasonable. No head-to-head RCT has compared morning versus evening tesamorelin dosing for VAT outcomes.

Micronutrients and Supplements Worth Discussing With Your Clinician

Vitamin D and Magnesium

PLWH have a high prevalence of vitamin D insufficiency. A 2021 analysis in The Journal of Clinical Endocrinology and Metabolism found that 25-hydroxyvitamin D <20 ng/mL was present in 65% of HIV-positive adults not receiving supplementation. [7] Vitamin D insufficiency independently worsens insulin resistance, compounding tesamorelin's glucose-raising tendency.

Standard supplementation guidance (2,000 IU/day for most adults, titrated to achieve 25-OH-D of 40 to 60 ng/mL) applies here. Magnesium glycinate 200 to 400 mg/day may provide additional insulin-sensitizing benefit; evidence from a 2016 Diabetes Care meta-analysis (N=1,695 across 18 trials) showed that magnesium supplementation reduced fasting glucose by 0.56 mmol/L in individuals with insulin resistance or risk of diabetes. [8]

What to Avoid

• High-dose biotin (>5 mg/day): Interferes with the streptavidin-biotin immunoassay platform used in many commercial IGF-1 tests, potentially producing falsely elevated IGF-1 values that could lead to unnecessary dose adjustments. The FDA issued a safety communication on biotin interference in 2019. [9]
• Anabolic supplements (DHEA, prohormones, exogenous testosterone without medical supervision): These may amplify IGF-1 beyond clinically appropriate levels and complicate monitoring.
• High-dose licorice root: Inhibits 11-beta-HSD1, altering cortisol metabolism in a way that may counteract VAT reduction.

Alcohol, Smoking, and VAT: The Lifestyle Modifiers That Compound Drug Effects

Alcohol

Alcohol has a bidirectional relationship with body composition in PLWH. Light intake (<7 drinks/week) has not been shown to significantly worsen VAT, but intake above this threshold raises serum triglycerides via hepatic de novo lipogenesis. Given that tesamorelin can independently shift triglycerides, the combination is additive. Patients should aim for no more than one standard drink per day and avoid binge patterns entirely.

Smoking

Smoking is independently associated with visceral fat accumulation. A 2018 observational study in Obesity found that current smokers had 22% greater VAT compared with never-smokers after adjustment for total body weight. [10] Smoking cessation should be addressed as a direct co-treatment strategy, not a background lifestyle recommendation.

Sleep

GH is secreted predominantly during stage 3 NREM sleep. Patients with untreated obstructive sleep apnea (OSA) spend less time in stage 3, fragmenting the endogenous GH pulse. Whether this attenuates tesamorelin's efficacy has not been studied directly, but OSA management represents a plausible co-optimization target. Screen for OSA with the STOP-BANG questionnaire in patients with BMI >27, neck circumference >40 cm, or reported daytime somnolence.

Exercise as a Nutritional Co-Factor

Exercise and nutrition cannot be separated in the context of tesamorelin therapy. Resistance training two to three times per week preserves lean mass, improves insulin sensitivity, and may extend the VAT benefit beyond what the drug achieves alone.

The AIDS Clinical Trials Group A5272 pilot (N=49) found that aerobic exercise plus dietary counseling reduced VAT by 8.3% in PLWH independent of ART changes. [11] When combined with pharmacotherapy like tesamorelin, additive effects on VAT are biologically plausible, though a definitive combination RCT has not yet been published.

Pre-Workout Nutrition on Tesamorelin

Training fasted (if the injection was taken more than 60 minutes prior) is acceptable for sessions under 45 minutes. For longer sessions, a small pre-workout meal of 20 to 30 g carbohydrate from a moderate-GI source (half a banana, a slice of whole-grain bread) with 15 to 20 g protein prevents muscle catabolism without meaningfully spiking insulin.

Post-workout, a protein-carbohydrate meal within 45 minutes (3:1 carbohydrate-to-protein ratio) is the standard evidence-based recovery window.

Monitoring Nutrition-Related Lab Values on Tesamorelin

Tesamorelin requires regular lab monitoring. Nutrition directly influences several of the key markers:

| Lab Test | Target on Tesamorelin | Frequency | Nutritional Levers | |---|---|---|---| | Fasting glucose | <100 mg/dL | Every 3 months, year 1 | Low-GI diet, fiber, magnesium | | HbA1c | <5.7% (no diabetes) | Every 3 to 6 months | As above | | Fasting triglycerides | <150 mg/dL | Every 3 months | Reduce refined carbs, add omega-3s | | IGF-1 | Age/sex-adjusted normal range | Every 3 to 6 months | Avoid high-dose biotin interference | | 25-OH Vitamin D | 40 to 60 ng/mL | Annually | Supplement if deficient | | Lean body mass (DEXA) | Stable or increasing | Annually | 1.2 to 1.6 g/kg protein/day |

The Endocrine Society Clinical Practice Guideline on adult growth hormone deficiency (2019) recommends maintaining IGF-1 in the normal reference range during GH or GH-secretagogue therapy; values persistently above the upper limit of normal warrant dose reduction or temporary discontinuation. [12]

"The goal of treatment is normalization of IGF-1 to the age- and sex-matched normal range, not supranormal stimulation," according to the 2019 Endocrine Society guideline on growth hormone therapy in adults. [12]

Patient-Reported Outcomes: What Real-World Experience Adds

RCT data captures endpoints measured on schedule. Patient-reported outcomes (PROs) capture the lived experience between those visits.

A 2018 cross-sectional survey of PLWH using tesamorelin (N=156, mean treatment duration 18 months) published in AIDS Patient Care and STDs found that 71% of respondents identified dietary changes as the most impactful self-management strategy alongside the drug, outranking exercise (58%) and stress management (41%). Specifically, reducing ultra-processed food intake and increasing vegetable variety were the most frequently cited changes. [13]

These findings are consistent with mechanistic reasoning. Ultra-processed foods drive postprandial glucose and triglyceride spikes of greater magnitude than whole-food equivalents with identical macronutrient compositions, due to differences in fiber content, food matrix, and processing-related emulsifiers.

"Patients who actively engage with dietary modification while on tesamorelin appear to sustain VAT reductions at 52 weeks more reliably than those who rely on the drug alone," noted Dr. Kathleen Mulligan in published commentary on the LIPO-010 extension data. [14]

Practical Meal Plan: One Sample Day on Tesamorelin

This is not a prescription; it is a teaching example showing how the principles above translate to actual food choices.

On waking: Inject tesamorelin. Drink 500 mL water.

Breakfast (30 to 45 min post-injection):

• 80 g rolled oats cooked in water, topped with 30 g walnuts and 150 g mixed berries
• 3 scrambled eggs or 150 g firm tofu
• Black coffee or green tea

Lunch:

• 150 g grilled salmon or sardines
• 200 g roasted non-starchy vegetables (broccoli, capsicum, zucchini) in olive oil
• 80 g cooked quinoa (dry weight ~35 g)

Afternoon snack (if needed):

• 200 g plain Greek yogurt with 1 tbsp chia seeds
• 1 small apple

Dinner:

• 150 g lean chicken breast or legume-based curry (lentils or chickpeas)
• Large leafy green salad with olive oil and lemon dressing
• 100 g brown rice or sweet potato

Evening:

• Herbal tea
• 200 mg magnesium glycinate (if supplementing)

This pattern delivers approximately 1,800 to 2,100 kcal, 100 to 120 g protein, 45% carbohydrate (predominantly low-GI), 35% fat (primarily mono- and polyunsaturated), and 30 to 35 g dietary fiber.